Gerlach M - Search Results

1

The AGNP-TDM expert group consensus guidelines: therapeutic drug monitoring in psychiatry.

Baumann P, Hiemke C, Ulrich S, Eckermann G, Gaertner I, Gerlach M, Kuss HJ, Laux G, Müller-Oerlinghausen B, Rao ML, Riederer P, Zernig G; Arbeitsge-meinschaft fur neuropsychopharmakologie und pharmakopsychiatrie. Baumann P, et al. Among authors: gerlach m. Pharmacopsychiatry. 2004 Nov;37(6):243-65. doi: 10.1055/s-2004-832687. Pharmacopsychiatry. 2004. PMID: 15551191 Review.

2

The molecular pharmacology of L-deprenyl.

Gerlach M, Riederer P, Youdim MB. Gerlach M, et al. Eur J Pharmacol. 1992 Jun 5;226(2):97-108. doi: 10.1016/0922-4106(92)90170-z. Eur J Pharmacol. 1992. PMID: 1639115 Review.

3

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

Gerlach M, Riederer P, Przuntek H, Youdim MB. Gerlach M, et al. Eur J Pharmacol. 1991 Dec 12;208(4):273-86. doi: 10.1016/0922-4106(91)90073-q. Eur J Pharmacol. 1991. PMID: 1815982 Review.

4

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

Gerlach M, Ben-Shachar D, Riederer P, Youdim MB. Gerlach M, et al. J Neurochem. 1994 Sep;63(3):793-807. doi: 10.1046/j.1471-4159.1994.63030793.x. J Neurochem. 1994. PMID: 7519659 Review.

5

Neuroprotective therapeutic strategies. Comparison of experimental and clinical results.

Gerlach M, Riederer P, Youdim MB. Gerlach M, et al. Biochem Pharmacol. 1995 Jun 29;50(1):1-16. doi: 10.1016/0006-2952(95)00051-z. Biochem Pharmacol. 1995. PMID: 7605334 Review. No abstract available.

6

Is selegiline neuroprotective in Parkinson's disease?

Gerlach M, Youdim MB, Riederer P. Gerlach M, et al. J Neural Transm Suppl. 1994;41:177-88. doi: 10.1007/978-3-7091-9324-2_24. J Neural Transm Suppl. 1994. PMID: 7931225 Review.

7

Effect of adding selegeline to levodopa in early, mild Parkinson's disease. "On treatment" rather than intention to treat analysis should have been used.

Gerlach M, Riederer P, Vogt H. Gerlach M, et al. BMJ. 1996 Mar 16;312(7032):704; author reply 704-5. BMJ. 1996. PMID: 8597750 Free PMC article. No abstract available.

8

Molecular mechanisms for neurodegeneration. Synergism between reactive oxygen species, calcium, and excitotoxic amino acids.

Gerlach M, Riederer P, Youdim MB. Gerlach M, et al. Adv Neurol. 1996;69:177-94. Adv Neurol. 1996. PMID: 8615127 Review. No abstract available.

9

[Pathogenesis and neuroprotective therapy trial in chronic degenerative diseases. Status of antioxidants].

Gerlach M, Riederer P. Gerlach M, et al. Med Klin (Munich). 1996 Mar 15;91(3):163-70. Med Klin (Munich). 1996. PMID: 8628203 Review. German. No abstract available.

10

Interleukin-1 beta and interleukin-6 are elevated in the cerebrospinal fluid of Alzheimer's and de novo Parkinson's disease patients.

Blum-Degen D, Müller T, Kuhn W, Gerlach M, Przuntek H, Riederer P. Blum-Degen D, et al. Among authors: gerlach m. Neurosci Lett. 1995 Dec 29;202(1-2):17-20. doi: 10.1016/0304-3940(95)12192-7. Neurosci Lett. 1995. PMID: 8787820

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters